Kirkpatrick Suriya, Campbell Karen, Harding Samantha, Rudd Sarah
Author Affiliations: North Bristol NHS Trust (Mrs Kirkpatrick, Dr Harding, and Ms Rudd); Edinburgh Napier University (Dr Campbell).
Cancer Nurs. 2024 Nov 25. doi: 10.1097/NCC.0000000000001417.
Hematological cancers have devastating effects on patients' physical, emotional, and psychosocial health. There is growing evidence to support the use of patient-reported outcome measures (PROMs) through validated tools. Although PROMs are widely adopted in oncology, uptake in hematology remains limited in routine clinical care.
This review seeks to explore the utility of PROMs in routine hematology clinical practice and to understand the extent and type of evidence in relation to benefits of PROMs to patients.
The review was conducted in accordance with the Joanna Briggs Institute methodology for scoping reviews and the Preferred Reporting Items for Systematic reviews and Meta-Analysis scoping review model for organizing information.
Ten thousand and seventy-one articles were identified, 110 full texts were reviewed, and 14 articles met the final inclusion criteria. More than 20 individual outcome measures were identified that fell into the following categories: accessibility and usability, self-efficacy, shared decision-making, and implementation.
Studies focused primarily on the choice of PROM, acceptability and usability, motivation for use, patient and healthcare professionals' experience of using PROMs, the stated value of PROMs, and implementation advice. However, there are limited published studies supporting how PROMs can be adopted into routine care for people with hematological cancer.
There are various validated PROMs but limited research on how to meaningfully implement them to improve clinical and patient outcomes in the routine care of hematology patients.
血液系统癌症对患者的身体、情感和心理社会健康具有毁灭性影响。越来越多的证据支持通过经过验证的工具使用患者报告结局测量指标（PROMs）。尽管PROMs在肿瘤学中被广泛采用，但在血液学领域，其在常规临床护理中的应用仍然有限。
本综述旨在探讨PROMs在常规血液学临床实践中的效用，并了解与PROMs对患者益处相关的证据范围和类型。
本综述按照乔安娜·布里格斯研究所的范围综述方法以及系统评价和Meta分析范围综述的首选报告项目模型进行信息整理。
共识别出10071篇文章，对110篇全文进行了审查，14篇文章符合最终纳入标准。确定了20多种个体结局测量指标，可分为以下几类：可及性和可用性、自我效能感、共同决策和实施。
研究主要集中在PROM的选择、可接受性和可用性、使用动机、患者和医疗保健专业人员使用PROM的经验、PROM的既定价值以及实施建议。然而，关于如何将PROMs纳入血液系统癌症患者常规护理的已发表研究有限。
有多种经过验证的PROMs，但关于如何在血液学患者的常规护理中有意义地实施这些指标以改善临床和患者结局的研究有限。
